key: cord-0900718-zzy8s78r
authors: Krumkamp, R.; Kreuels, B.; Jaeger, V. K.; May, J.; Mikolajczyk, R.; Karch, A.
title: Negative SARS-CoV-2 PCR or rapid antigen test result and the subsequent risk of being infectious: a mathematical simulation study
date: 2021-03-12
journal: nan
DOI: 10.1101/2021.03.12.21253440
sha: 43fd1578258f74ee710bf0802b556d5f0f0a9f72
doc_id: 900718
cord_uid: zzy8s78r

Background. A considerable proportion of SARS-CoV-2 transmission occurs from asymptomatic and pre-symptomatic cases. Therefore, different polymerase chain reaction (PCR)- or rapid antigen test (RAT)-based approaches are being discussed and applied to identify infectious cases that would have gone undetected (e.g., in nursing homes). In this article, we provide a framework to estimate the time-dependent risk of being infectious after a negative SARS-CoV-2 test and we simulate the number of expected cases over time in populations of individuals who initially tested negative. Methods. A Monte Carlo approach is used to simulate infections that occurred over a one-week period in populations with 1,000 individuals following a negative SARS-Cov-2 test. Parameters representing the application of PCR tests or RATs are utilized, and SARS-CoV-2 7-day incidences between 25 and 200 per 100,000 people are considered. Simulation results are compared to case numbers predicted via a mathematical equation. Results. The simulations showed a linear increase in cases over time in populations of individuals who initially tested SARS-CoV-2 negative. The different false negative rates of PCR tests and RATs have a strong impact on the number of simulated cases. The simulated and the mathematically predicted case numbers were comparable. However, Monte Carlo simulations highlight that, due to random effects, infectious cases can exceed predicted case numbers even shortly after a test was conducted. Conclusions. The analysis demonstrates that the number of infectious cases in a population can be effectively reduced by the screening of asymptomatic individuals. However, the time since the negative test and the underlying SARS-CoV-2 incidence are critical parameters in determining the observed subsequent number of cases in tested populations.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 12, 2021. ; https://doi.org/10.1101/2021.03.12.21253440 doi: medRxiv preprint numbers even shortly after a test was conducted. 48

Conclusions. The analysis demonstrates that the number of infectious cases in a population 49 can be effectively reduced by the screening of asymptomatic individuals. However, the time 50 since the negative test and the underlying SARS-CoV-2 incidence are critical parameters in 51 determining the observed subsequent number of cases in tested populations. 52 53 Key words: SARS-CoV-2, negative diagnostic test, infectiousness, asymptomatic 54 transmission, simulation study 55 . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 12, 2021. ; https://doi.org/10.1101/2021.03.12.21253440 doi: medRxiv preprint 3 Background 56 A considerable proportion of individuals with SARS-CoV-2 infection are free of 57 symptoms or only show very mild symptoms. However, transmission can occur from both 58 asymptomatic and pre-symptomatic cases [1, 2] . Different PCR (polymerase chain reaction) or 59 rapid antigen test (RAT)-based approaches are currently being considered or RAT results are available within 20-30 min. However, these tests have a lower sensitivity 69 than PCR tests [5] . The time between sample taking and critical event (e.g., air travel) is a 70 crucial parameter in determining the current risk of being infectious. An individual who has 71 tested negative may be in the latent period of infection at sampling and could progress to an 72 infectious state immediately thereafter. As time since testing increases, people with a previous 73 negative test results will have the same risk of being infectious as the underlying population. 74

In this article, we provide a framework to estimate the time-dependent risk of being 75 infectious after a negative PCR test or RAT, and we simulate the number of expected cases 76 over time in populations of individuals who initially tested negative. 77

We simulate infections that occur over a one-week period in a group of people who are 79 SARS-CoV-2 negative at t0. For the simulations we assume that the population is entirely 80 . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint 

The expected number of infectious cases over time (Ct) within a population which had a 117 negative test result for SARS-CoV-2 can be described mathematically. In each scenario, Ct is 118 based on the actual daily incidence of infectious cases per 100,000 people (I, representing the 119 true number of infectious cases in a population), and the rate of prevalent cases corresponds to 120 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 12, 2021. ; https://doi.org/10.1101/2021.03.12.21253440 doi: medRxiv preprint 6 the number of cases becoming non-infectious is balanced. Thereafter, the previously negative 125 population shows case frequencies as expected by the underlying incidence of infection. 126

Assuming homogeneous case occurrence over time and taking the FNR of the test into 127 consideration, the number of cases in a previously negative population at a particular day 128 (defined in t) after negative testing can be estimated by 129 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint Due to the assumed FNR of 3% for PCR tests, infectious cases occurred as early as at the 161 start of some simulations. No infectious cases were observed at the start in 99% of 162 simulations when the reported 7-day incidence was 25/100,000, in 98% of simulations when 163 incidence was 50/100,000, in 95% when incidence was 100/100,000, and in 91% when 164 incidence was 200/100,000. After one day (24 hours), no cases occurred at the different 165 incidence levels in 94%, 88%, 80% and 64% of simulations, and after two days (48 hours) in 166 85%, 71%, 54% and 28% of the simulations. After 4.5 days (108 hours), the simulated case 167 numbers started to stabilise and no further case increase was observed. Eventually, by the end 168 of the simulation period (7 days) no infectious cases occurred in 67%, 43%, 20% and 4% of 169 the simulations, which represents distributions in non-selected populations. Throughout time, is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 12, 2021. ; https://doi.org/10.1101/2021.03.12.21253440 doi: medRxiv preprint 8 multiple infections were likely to occur in scenarios with higher incidences. At a reported 7-171 day incidence of 25/100,000, a prevalence of 4 simultaneous cases was never exceeded. 172 However, after 80 hours, 51 hours and 14 hours, more than 4 cases were observed in 173 simulations based on 7-day incidences of 50, 100 and 200 cases per 100,000, respectively. 174

The FNR of the RAT was set to 20%, resulting in a lower proportion of simulations 175 without any infectious cases at the simulation start. No infectious cases were observed at the 176 start of the simulations in 92%, 86%, 74% and 55% of the simulations at incidence levels of 177 25, 50, 100 and 200 per 100,000, respectively. After one day (24 hours), no cases occurred in 178 85%, 72%, 53% and 28% of simulations, and after two days (48 hours) in 79%, 61%, 38% 179 and 15% of the simulations, respectively. After 4 days (96 hours), the estimated number of 180 cases started to stabilise and no infectious cases had occurred by the end of the simulation 181 period in 67%, 44%, 19% and 4% of the simulations, which is comparable to the numbers 182 calculated by the PCR scenarios. Similar to the PCR test, in simulations based on a reported 183 7-day incidence of 25/100,000, no simulation showed more than 4 cases; however, at 7-day 184 incidences of 50,100 and 200/100,000, after 48 hours, 16 hours, 1 hour, respectively more 185 than 4 cases were observed. 186 . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 12, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint Our analysis shows that testing asymptomatic individuals with PCR tests or RATs can 216 reduce the number of infectious cases within populations effectively. We provide an easily 217 applicable mathematical formula to estimate the expected case numbers over time using the 218 disease incidence, the average infectious period and the time that has passed since a test was 219 administered. However, the Monte Carlo simulations performed in our analysis highlight 220 how, due to random effects, infectious cases can exceed these expected numbers even shortly 221 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint important that the test is carried out immediately before a critical event takes place. The 234 higher FNR still bears the risk of missing infectious cases, but the immediate application 235 reduces the number of cases which may emerge before the critical event takes place. 236

Simplifying assumptions that were made to illustrate principles of SARS-CoV-2 testing 237 should be considered when interpreting the results. Random case occurrence was assumed; 238 however, SARS-CoV-2 is reported to spread in clusters and via super-spreading events [13] . 239

Thus, in the case that testing is performed on a group of people where a superspreading event 240 occurred (e.g., residents and personnel of a nursing facility with an ongoing SARS-CoV-2 241 outbreak), the prevalence of infectious cases would be considerably higher compared to the 242 numbers reported here. The proportion of infectious cases without or with only mild 243 symptoms was set to 65%. However, a correct estimate of this proportion is subject to several 244 methodological limitations that make interpretation of the reported frequencies of symptoms 245 among SARS-CoV-2 cases difficult [14] . Additionally, we assume that the remaining 35% of 246 cases are recognized by a health care system and they contribute to the observed incidence at 247 . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 12, 2021. ; https://doi.org/10.1101/2021.03.12.21253440 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 12, 2021. ; https://doi.org/10.1101/2021.03.12.21253440 doi: medRxiv preprint

Temporal dynamics in viral 284 shedding and transmissibility of COVID-19

Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility

Put to the test: use of rapid testing technologies 290 for covid-19

Federal Foreign Office. Entry restrictions and quarantine regulations in Germany 292

Considerations for 295 diagnostic COVID-19 tests

Shedding of infectious virus in hospitalized patients with coronavirus disease-299 2019 (COVID-19): duration and key determinants. medRxiv

Antigen-detection in the diagnosis of SARS-CoV-2 306 infection using rapid immunoassays

Severe Acute Respiratory Syndrome Coronavirus 2 From Diagnostic Samples

Viral 313 RNA load as determined by cell culture as a management tool for discharge of SARS

CoV-2 patients from infectious disease wards

Test sensitivity 317 is secondary to frequency and turnaround time for COVID-19 surveillance

R: A Language and Environment for Statistical Computing

Austria: R Foundation for Statistical Computing

Clustering and 322 superspreading potential of SARS-CoV-2 infections in Hong Kong

Towards an accurate and 325 systematic characterisation of persistently asymptomatic infection with SARS-CoV-2

Inferred duration 328 of infectious period of SARS-CoV-2: rapid scoping review and analysis of available 329 evidence for asymptomatic and symptomatic COVID-19 cases

Optimizing COVID-19 surveillance in long-term care facilities: a modelling study

control SARS-CoV-2 transmission, concluding that asymptomatic individuals should be 260 considered in testing strategies. Effective surveillance depends largely on the frequency of 261 testing and the speed of reporting, and is only marginally improved by high test sensitivity 262 [11] . These studies highlight the effect of testing asymptomatic individuals to control the 263 spread of SARS-CoV-2, which is also supported by our study. With the current analysis we 264 provide the rationale for estimating the risk of being infectious after a negative diagnostic test. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprintThe copyright holder for this this version posted March 12, 2021. ; https://doi.org/10.1101/2021.03.12.21253440 doi: medRxiv preprint It is made available under a perpetuity.is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprintThe copyright holder for this this version posted March 12, 2021. ; https://doi.org/10.1101/2021.03.12.21253440 doi: medRxiv preprint